The potential benefit of allergen immunotherapy is largely predetermined by
the appropriate selection of constituent allergens. Appropriate vaccine fo
rmulation is dependent on knowledge of patient's outdoor and indoor aeroall
ergen exposure and allergic sensitivity. This article addresses the geograp
hic distribution of outdoor and indoor aeroallergen sources and sting Hymen
optera. Cross-reactivity data are summarized to facilitate vaccine formulat
ion.